Frequency, risk factors and prophylaxis of infection in ANCA‐associated vasculitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2362|45|3|346-368

ISSN： 0014-2972

Source： EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol.45, Iss.3, 2015-03, pp. : 346-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Addition of Infliximab to Standard Therapy for ANCA-Associated Vasculitis

By  

Nephron Clin Pract, Vol. 117, Iss. 2, 2010-08 ,pp. : c89-c97

Karger

Access to resources Recommend Favorite

Rituximab in ANCA-Associated Vasculitis: Fad or Fact?

By  

Nephron Clin Pract, Vol. 118, Iss. 2, 2010-12 ,pp. : c182-c188

Karger

Access to resources Recommend Favorite

Phosphorylcholine antibodies are diminished in ANCA‐associated vasculitis

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 7, 2015-07 ,pp. : 686-691

John Wiley & Sons Inc

Access to resources Recommend Favorite

Limitations of Standard Immunosuppressive Treatment in ANCA-Associated Vasculitis and Lupus Nephritis

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 205-215

Karger

Access to resources Recommend Favorite

Diffuse alveolar hemorrhage secondary to ANCA‐associated vasculitis in a patient with Down syndrome

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 2, 2015-04 ,pp. : e45-e47

John Wiley & Sons Inc

Access to resources Recommend Favorite